THE MOUNT VERNON MARIE CURIE RESEARCH WING TRUST

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -22.8%

  £118,309 → £91,346

• Cash

  -26.1%

  £289,792 → £214,034

• Net assets

  +5.3%

  £1,569,022 → £1,652,651

• Employees

  0%

  2 → 2

• Operating profit

  -1,713%

  £2,636 → -£42,518

• Profit before tax

  -1,713%

  £2,636 → -£42,518

• Wages

  +3.6%

  £32,306 → £33,481

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. THE MOUNT VERNON MARIE CURIE RESEARCH WING TRUST 2002-04-05 → present
2. MARIE CURIE RESEARCH WING TRUST 2000-11-20 → 2002-04-05

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Xeinadin Audit Limited

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the trust's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Significant events

• “In May 2024 the charity supported members of the Head & Neck oncology team to attend the British Association of Head & Neck Oncology meeting, topic for 2024 was 'data outcomes in Head & Neck cancer.' For ESTRO 2024 Dr Abdul-Latif presented 'Salvage brachytherapy in second ipsilateral breast tumour event: Relating dosimetry with late toxicity', whilst Drs Chowdhury's, Scott and Guppy's poster was accepted for The UK Interdisciplinary Breast Cancer Symposium held in January 2024; Titled Sleep disturbance amongst the breast cancer population: a single-centre prospective experience'.”
• “During the year we accepted the following clinical visitors to observe Brachytherapy procedures under the guidance of Professor Hoskin; Dr Wiwatchai Sittiwong from Siriraj Hospital Thailand, for a period of 1 year also Dr Aaron Kent from Australia.”
• “The Mount Vernon Marie Curie Research Wing Trust is continuing to support MD's for Dr Amani Chowdhury and Dr Chloe Brooks by sponsoring tuition fees for the duration of their course at Manchester University.”
• “In 2023/24 there were 65 peer review publications and abstracts arising from this work.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.